Skip to main content
BKYI
NASDAQ Technology

BIO-key Projects 50% H1 Revenue Growth and Profitability Turnaround

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$0.615
Mkt Cap
$6.837M
52W Low
$0.49
52W High
$1.97
Market data snapshot near publication time

summarizeSummary

BIO-key International, Inc. announced strong first-half 2026 guidance, projecting a 50% increase in revenues to $5 million and a return to positive net income, driven by software license renewals and hardware contracts.


check_boxKey Events

  • Strong H1 2026 Guidance

    Projects 50% revenue growth to approximately $5 million for the first half of 2026, up from $3.3 million in 1H 2025.

  • Return to Profitability

    Expects positive net income in 1H 2026, a significant improvement from a $1.9 million net loss in 1H 2025.

  • Q1 & Q2 Revenue Growth

    Anticipates Q1 2026 revenues to increase 37% to $2.2 million and Q2 2026 revenues to grow 65% to $2.8 million.

  • Key Contract Wins

    Performance is bolstered by a $1.04 million expanded software license renewal and over $1 million in hardware contracts.


auto_awesomeAnalysis

This 8-K formalizes the positive business outlook previously reported by news outlets on April 16, detailing significant revenue growth expectations for the first half of 2026, including a 37% increase in Q1 and 65% in Q2. Crucially, the company anticipates a shift from a net loss to positive net income, indicating improved operational efficiency and financial health. The projected $5 million in revenue for the first half is substantial for a company of this size, suggesting a significant increase in business activity and market penetration, particularly with key software license renewals and new hardware contracts. This guidance provides a strong positive signal for the company's near-term financial trajectory.

At the time of this filing, BKYI was trading at $0.62 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.8M. The 52-week trading range was $0.49 to $1.97. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BKYI - Latest Insights

BKYI
Apr 29, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
8
BKYI
Apr 24, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
BKYI
Apr 22, 2026, 4:45 PM EDT
Source: GlobeNewswire
Importance Score:
8
BKYI
Apr 20, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
BKYI
Apr 16, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
BKYI
Mar 31, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
BKYI
Mar 31, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
BKYI
Mar 27, 2026, 9:51 AM EDT
Source: Reuters
Importance Score:
7
BKYI
Mar 16, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
7
BKYI
Mar 06, 2026, 5:00 PM EST
Filing Type: PRE 14A
Importance Score:
8